申请人:——
公开号:US20030055037A1
公开(公告)日:2003-03-20
Benzimidazole and indole derivatives that act as selective modulators of CRF 1 receptors are provided. These compounds are useful in the treatment of a number of CNS and periphereal disorders, particularly stress, anxiety, depression, cardiovascular disorders, and eating disorders. Methods of treatment of such disorders and well as packaged pharmaceutical compositions are also provided.
Compounds of the invention are also useful as probes for the localization of CRF receptors and as standards in assays for CRF receptor binding. Methods of using the compounds in receptor localization studies are given.
提供作为CRF 1受体选择性调节剂的苯并咪唑和吲哚衍生物。这些化合物在治疗多种中枢神经系统和外周疾病方面具有用途,特别是应激、焦虑、抑郁、心血管疾病和进食障碍。还提供了治疗这些疾病的方法以及包装的药物组合物。发明的化合物还可用作CRF受体定位的探针以及CRF受体结合测定的标准。提供了使用这些化合物进行受体定位研究的方法。